Sanofi India Limited (NSE: SANOFI)

India flag India · Delayed Price · Currency is INR
6,135.35
-47.35 (-0.77%)
Dec 24, 2024, 3:29 PM IST
53.20%
Market Cap 141.01B
Revenue (ttm) 28.23B
Net Income (ttm) 4.60B
Shares Out n/a
EPS (ttm) 199.60
PE Ratio 30.67
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,183
Open 6,184.00
Previous Close 6,182.70
Day's Range 6,049.00 - 6,209.70
52-Week Range 5,892.80 - 10,525.00
Beta 0.30
Analysts n/a
Price Target n/a
Earnings Date Feb 21, 2025

About Sanofi India

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through indepe... [Read more]

Sector Healthcare
Founded 1956
Employees 2,174
Stock Exchange National Stock Exchange of India
Ticker Symbol SANOFI
Full Company Profile

Financial Performance

In 2023, Sanofi India's revenue was 28.51 billion, an increase of 2.92% compared to the previous year's 27.70 billion. Earnings were 6.03 billion, a decrease of -2.85%.

Financial Statements

News

Sanofi Consumer makes its debut on stock exchanges

Sanofi Consumer Healthcare has been listed on the BSE and NSE after its demerger from Sanofi India. Approved by the National Company Law Tribunal, this move aligns with Sanofi's global strategy. The c...

3 months ago - The Times of India